Humana Inc (HUM) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.

Total Cash From Operating Activities Chart for Humana Inc

Humana Inc (HUM) operating cash flow for FY2025 was USD 921.0M, a -68.9% change from FY2024. Humana Inc's operating cash flow grew from USD 758.3M in 1990 to USD 921.0M in 2025 (21.5% over 35 years). Operating cash flow compound annual growth rate: 5-year CAGR of -30.4%, 10-year CAGR of 0.6%, 20-year CAGR of 2.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$44.10B
Implied Share Price
$367.24
Enterprise Value
$50.84B
Revenue (TTM)
$145.68B
EBITDA
$3.60B
Profit Margin
0.88%
Trailing P/E
34.35
Forward P/E
39.84
Price/Book (MRQ)
2.26
Price/Sales (TTM)
0.30
EV/EBITDA
0.00
EV/Revenue
0.35
Dividend Yield
0.97%
Book Value
$154.75
Free Cash Flow (FY2025)
$375.00M
Free Cash Flow Yield
0.85%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.